Optimal treatment for chronic active Epstein-Barr virus disease
- PMID: 19032417
- PMCID: PMC2776035
- DOI: VSports - 10.1111/j.1399-3046.2008.01095.x
Optimal treatment for chronic active Epstein-Barr virus disease
References
-
- COHEN JI. Epstein-Barr virus infection. N Engl J Med. 2000;343:481–492. - PubMed
-
- STRAUS SE. Acute progressive Epstein-Barr virus infections. Ann Rev Med. 1992;42:437–449. - PubMed
-
- KIMURA H, HOSHINO Y, KANEGANE H, TSUGE I, OKAMURA T, KAWA K, MORISHIMA T. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood. 2001;98:280–6. - VSports app下载 - PubMed
-
- KIMURA H, HOSHINO Y, HARA S, SUGAYA N, KAWADA J, SHIBATA Y, KOJIMA S, NAGASAKA T, KUZUSHIMA K, MORISHIMA T. Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection. J Infect Dis. 2005;191:531–9. - PubMed
-
- KIMURA H, MORISHIMA T, KANEGANE H, OHGA S, HOSHINO Y, MAEDA A, IMAI S, OKANO M, MORIO T, YOKOTA S, TSUCHIYA S, YACHIE A, IMASHUKU S, KAWA K, WAKIGUCHI H. Prognostic factors for chronic active Epstein-Barr virus infection. J Infect Dis. 2003;187:527–33. - PubMed (VSports app下载)
Publication types
MeSH terms
- V体育官网入口 - Actions
- "V体育安卓版" Actions
- VSports注册入口 - Actions
- Actions (VSports)
Grants and funding
LinkOut - more resources
Full Text Sources (V体育平台登录)
Other Literature Sources
Medical
